Thyroid disorder — all decisions

The appeal for service connection for hypothyroidism was withdrawn by the appellant before a decision was made.

The Board remands the claim for an initial compensable evaluation for hypothyroidism and considers a secondary service connection claim for stroke residuals.

The Board granted service connection for myasthenia gravis as secondary to peripheral neuropathy and earlier effective dates for diabetes mellitus type II, peripheral neuropathy of the bilateral upper and lower extremities. The claims for initial ratings were denied or remanded.

The Board denied service connection for thyroid disability, prostate cancer, high blood pressure, and diabetes as the evidence did not support a finding that these conditions began during active service or were otherwise related to an in-service injury, event, or disease.

The Board denied service connection for hypothyroidism, bradycardia, and hyperlipidemia as the evidence did not support a finding that these conditions were related to the Veteran's active duty service or herbicide exposure.

The Board granted service connection for peripheral neuropathy and hypertension, but denied service connection for chronic obstructive pulmonary disease (COPD) and an initial compensable rating for hypothyroidism. Tinnitus was also granted.

The Board denied earlier effective dates for the grants of service connection and special monthly compensation, as well as ratings for various conditions.

The Board granted service connection for parathyroid adenoma residuals as secondary to in-service toxic exposure risk activity (TERA) based on the Veteran's conceded AFFF exposure.

The Board granted service connection for atrial fibrillation and hypothyroidism, but denied a compensable disability rating for hypertension. The Board also granted a 60 percent disability rating for asbestos related pleural disease with pleural effusion, parenchymal disease, and COPD.

The Board denied the Veteran's claim for an initial compensable disability rating for hypothyroidism as the evidence did not show that her symptoms warranted a higher rating.

The Board remands the issues of entitlement to a compensable evaluation for service-connected thyroid enlargement (non toxic), benign prostatic hyperplasia, and hypertension due to additional development needed.

The Board remands the claim for service connection of residuals of papillary thyroid carcinoma post thyroidectomy, to include acquired hypothyroidism and neck scar, due to pre-decisional duty to assist errors.

The Board granted the restoration of a 60 percent rating for the Veteran's thyroid disability, effective December 1, 2023.

The Board denied service connection for bronchiectasis and thyroid nodular disease, non-malignant as the evidence did not support a current diagnosis of these conditions or a link to in-service events.

The Board remands the claims for service connection for diabetes, hypertension, and hypothyroidism to verify the Veteran's reported exposure to herbicide agents and sarin gas during his service in Okinawa.

The Board granted service connection for a thyroid disorder, finding that the Veteran's preexisting condition was aggravated by his active service.

The Board granted service connection for chronic lymphocytic thyroiditis as secondary to the Veteran's service-connected hypothyroidism.

The Board granted an initial 10 percent rating for hypothyroidism status post thyroidectomy.

The Board denied the veteran's claims for service connection for chronic pharyngitis and hypothyroidism, as there was no current diagnosis of these conditions. The claims for posttraumatic stress disorder, tachycardia as secondary to major depressive disorder, and major depressive disorder were remanded due to inadequate notice of a scheduled VA examination.

The Board granted service connection for hypothyroidism, which is presumed to be related to the Veteran's exposure to herbicide agents during his service in Vietnam.